Stock data
Allarity Therapeutics, Inc. (ALLR)
Allarity Therapeutics, Inc. (ALLR) reported net income of -US$11.23M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$12.61M | -US$11.23M | — |
| 2024 | — | — | -US$27.24M | -US$24.52M | — |
| 2023 | — | — | -US$17.13M | -US$11.90M | — |
| 2022 | — | -US$2.27M | -US$34.46M | -US$16.06M | — |
| 2021 | — | — | -US$26.56M | -US$26.65M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$3.40M | — |
| 2026-03-31 | — | -US$2.75M | — |
| 2025-12-31 | — | -US$3.37M | — |
| 2025-09-30 | — | -US$2.81M | — |
| 2025-06-30 | — | -US$2.32M | — |
| 2025-03-31 | — | -US$2.73M | — |
| 2024-12-31 | — | -US$7.45M | — |
| 2024-09-30 | — | -US$11.59M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.